BioAge Labs (BIOA) Depreciation & Amortization (CF) (2023 - 2026)
BioAge Labs (BIOA) posted Depreciation & Amortization (CF) of $100000.0 for Q1 2026, little changed sequentially from $100000.0 in Q4 2025, and little changed YoY from $100000.0 in Q1 2025.
BioAge Labs (BIOA) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
BioAge Labs has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $400000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $200000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) held at $100000.0 in Q1 2026 per BIOA's latest filing, from $100000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $100000.0 in Q3 2023 and troughed at $100000.0 in Q3 2023.
- A 4-year average of $100000.0 and a median of $100000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The widest YoY moves for Depreciation & Amortization (CF): up 0.0% in 2024, down 0.0% in 2024.
- Over 4 years, Depreciation & Amortization (CF) stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $100000.0, $100000.0, and $100000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | 70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |